PLYMOUTH MEETING, Pa., Oct. 30, 2024 /PRNewswire/ — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) (the “Company”) today announced the pricing of the previously announced underwritten public offering of an aggregate of 8,000,000 shares of the […]
Tag: Harmony Biosciences
HARMONY BIOSCIENCES HIGHLIGHTS NEW DATA, ROBUST LATE-STAGE PIPELINE WITH NEAR-TERM VALUE CREATION OPPORTUNITIES AND ITS BOLD NEW VISION AT INVESTOR DAY
PLYMOUTH MEETING, Pa., Oct. 1, 2024 /PRNewswire/ — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), will be providing a comprehensive pipeline update at its Investor Day event today, showcasing new data from its orexin-2 receptor agonist, next-generation […]
